In the Basque Country, the BioPraxis Group is building a pharmaceutical complex for the research and development of innovative drugs obtained mainly through biotechnological processes, and which may fill the treatment gaps presently affecting serious diseases, even if they are only of a minority nature.
This scientific and industrial complex will house the following centers: